Study summary · 2025 · Evidence review
RPM and hospital use across chronic diseases
RPM may modestly reduce the proportion of patients hospitalized; broader utilization effects remain uncertain.
Summary by Vironix Health · Source review: November 11, 2026
How we select and interpret evidence
Original publication
Geir Smedslund; Nina Østerås; Christine Hillestad Hestevik
Diakonhjemmet Hospital and Norwegian Institute of Public Health, Oslo, Norway
JMIR mHealth and uHealth · Online: · Issue: 2025
Journal version of record; earlier JMIR preprint not counted separately. · Full text consulted.
What was studied
- Design
- Evidence review
- Population
- People with noncommunicable diseases
- Sample
- 40 randomized trials
- Intervention
- Digital health-data transmission to care teams
- Comparator
- Usual care
- Follow-up
- Varied by trial
- Review search cutoff
- 2024-06
- Setting
- Multiple countries; predominantly high-income settings
Methods
Random-effects synthesis of randomized trials, with risk-of-bias and GRADE assessments.
Findings
Hospitalization risk ratio was 0.86 (95% CI 0.77–0.95; low certainty). Length of stay differed by −0.84 days (95% CI −1.61 to −0.06; low certainty). Emergency-visit effects were unclear.
Limitations
Only 8 of 40 trials had low risk of bias; 16 had some concerns and 16 high risk. Interventions included symptom reporting as well as measurements. Admission counts and some outpatient endpoints were inconclusive; certainty ranged from moderate to very low.
What this means for care delivery
Use condition-specific evidence alongside this broad review; it does not establish that every RPM service reduces admissions or spending.